Signaling pathways essential for triple-negative breast cancer stem-like cells.

Stem Cells
Sidse Ehmsen, Henrik J Ditzel

Abstract

Since the discovery of breast cancer stem cells (CSCs), a significant effort has been made to identify and characterize these cells. It is a generally believe that CSCs play an important role in cancer initiation, therapy resistance, and progression of triple-negative breast cancer (TNBC), an aggressive breast cancer subtype with poor prognosis. Thus, therapies targeting these cells would be a valuable addition to standard treatments that primarily target more differentiated, rapidly dividing TNBC cells. Although several cell surface and intracellular proteins have been described as biomarkers for CSCs, none of these are specific to this population of cells. Recent research is moving toward cellular signaling pathways as targets and biomarkers for CSCs. The WNT pathway, the nuclear factor-kappa B (NF-κB) pathway, and the cholesterol biosynthesis pathway have recently been identified to play a key role in proliferation, survival, and differentiation of CSCs, including those of breast cancer. In this review, we assess recent findings related to these three pathways in breast CSC, with particular focus on TNBC CSCs, and discuss how targeting these pathways, in combination with current standard of care, might prove effective and im...Continue Reading

References

Sep 4, 1998·Science·T C HeK W Kinzler
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·M ShtutmanA Ben-Ze'ev
Oct 9, 1999·The American Journal of Pathology·T BrabletzT Kirchner
Aug 30, 2000·Nature·C M PerouD Botstein
Jan 17, 2002·The Journal of Pathology·Sze Chuen Cesar WongW L Wendy Hsiao
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Jun 28, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen R D JohnstonAngela Howes
Jan 2, 2004·Breast Cancer Research and Treatment·George N NaumovAnn F Chambers
Nov 13, 2004·Breast Cancer Research : BCR·Gabriela DontuMax S Wicha
Jan 5, 2007·Proceedings of the National Academy of Sciences of the United States of America·Wendy A WoodwardJeffrey M Rosen
Feb 6, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cornelia LiedtkeLajos Pusztai
Mar 15, 2008·Current Opinion in Cell Biology·He Huang, Xi He
Apr 10, 2008·International Journal of Cancer. Journal International Du Cancer·François BertucciDaniel Birnbaum
May 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eva S Thomas
Jun 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Madhuri Kakarala, Max S Wicha
Mar 28, 2009·The Journal of Biological Chemistry·Heng ZhangKun-Liang Guan
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tomonori TaneiShinzaburo Noguchi
Apr 17, 2010·The American Journal of Pathology·Andrey I KhramtsovKathleen H Goss
Jun 10, 2010·Cytometry. Part B, Clinical Cytometry·Vera S DonnenbergAdam M Brufsky
Jul 27, 2010·The International Journal of Biochemistry & Cell Biology·Sara Rodríguez-EnríquezRafael Moreno-Sánchez
Aug 13, 2010·Molecular Pharmacology·Philippe de MedinaMarc Poirot
Jan 15, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ana M Gonzalez-AnguloFunda Meric-Bernstam
Jun 3, 2011·The Journal of Clinical Investigation·Brian D LehmannJennifer A Pietenpol
Aug 5, 2011·Journal of the National Cancer Institute·Thomas P AhernTimothy L Lash
Sep 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Erina VlashiFrank Pajonk
Jan 24, 2012·Cell·William A Freed-PastorCarol Prives
Feb 4, 2012·Genes, Chromosomes & Cancer·Xiang JiaoTobias Sjöblom
Mar 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Kathryn C DavidsonRandall T Moon
May 19, 2012·Stem Cells·Christophe GinestierEmmanuelle Charafe-Jauffret

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.